Bill > A09248

This bill establishes the New York State Pharmaceutical Drug Manufacturer and Wholesaler Disclosure Act, which requires pharmaceutical drug manufacturers and wholesalers to annually report to the New York Department of Health all gifts valued at $75 or more that they provide to health care practitioners. The legislation aims to increase transparency in the pharmaceutical industry by mandating that these companies disclose details such as the name and contact information of the gift recipient, a description of the gift, and its monetary value. Gifts that are exempt from disclosure include those under $75, payments for clinical trials, scholarships for medical professionals, unrestricted grants for medical education, prescription drug rebates, and free drug samples. The bill requires the Department of Health to publish an annual consumer guide with this information, making it freely available to the public through various channels including local aging offices, public libraries, and the department's website. The commissioner of health is authorized to impose penalties for non-compliance, with potential fines up to $50 per day for late reporting or up to $3,000 for each violation. The legislative intent behind this bill is to provide consumers with information about potential influences on their healthcare providers' prescribing practices, recognizing the significant marketing expenditures of pharmaceutical companies and their potential impact on medical decision-making.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A9248